Strengthening regulatory approvals for new contact lens products
First written in FY2017. 1 of 3 entries say "Advanced", first in FY2018. Latest entry: FY2019.
No other company in this theme has enough history to compare yet.
- FY2019RestatedAnnual report
「During the fiscal year, research and development activities consisted primarily of obtaining the approvals required to launch new contact lens products. Total research and development expenses for the fiscal year were ¥32.719 million.」
The company’s main research and development activity was obtaining approvals for new contact lens products, and it recorded ¥32.719 million in research and development expenses. - FY2018AdvancedAnnual report
「For cosmetic contact lenses®, the company changed the corporate name of 株式会社メリーサイト, which manufactures and sells contact lenses, to ＳＨＯ－ＢＩ Ｌａｂｏ株式会社 in October 2018, unified the organisation, and advanced research and development, including pursuing regulatory approvals for new products.」
The company outlined specific organisational measures, including changing メリーサイト’s corporate name, unifying the organisation, obtaining regulatory approvals for new products and strengthening research and development. - FY2017First statedAnnual report
「株式会社メリーサイト, which manufactures and sells contact lenses, is conducting research and development aimed at strengthening the acquisition of regulatory approvals for new products.」
The company has specified a measure to conduct research and development at メリーサイト to strengthen the acquisition of regulatory approvals for new products.